Total Payments
$204,110
2024 Payments
$37,030
Companies
14
Transactions
169
Medicare Patients
307
Medicare Billing
$26,274
Payment Breakdown by Category
Consulting$137,802 (67.5%)
Other$51,429 (25.2%)
Travel$11,515 (5.6%)
Food & Beverage$3,326 (1.6%)
Education$38.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $137,802 | 35 | 67.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,429 | 55 | 25.2% |
| Travel and Lodging | $11,515 | 40 | 5.6% |
| Food and Beverage | $3,326 | 37 | 1.6% |
| Education | $38.40 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Health Care AG | $51,305 | 11 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $36,593 | 16 | $0 (2024) |
| CSL Behring | $30,206 | 50 | $0 (2024) |
| Shire North American Group Inc | $28,086 | 33 | $0 (2019) |
| Genentech USA, Inc. | $14,435 | 17 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,610 | 2 | $0 (2022) |
| Novo Nordisk Inc | $6,462 | 6 | $0 (2017) |
| Spark Therapeutics, Inc. | $6,205 | 4 | $0 (2019) |
| Seattle Genetics, Inc. | $5,892 | 12 | $0 (2018) |
| Genentech, Inc. | $5,243 | 7 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,030 | 15 | BioMarin Pharmaceutical Inc. ($29,672) |
| 2023 | $19,376 | 19 | CSL Behring ($8,674) |
| 2022 | $44,407 | 37 | CSL Behring ($15,115) |
| 2021 | $8,820 | 10 | Novo Nordisk Health Care AG ($5,400) |
| 2020 | $9,851 | 3 | Novo Nordisk Health Care AG ($5,400) |
| 2019 | $31,497 | 21 | Shire North American Group Inc ($14,341) |
| 2018 | $21,103 | 21 | Novo Nordisk Health Care AG ($7,020) |
| 2017 | $32,026 | 43 | Shire North American Group Inc ($9,807) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 10/28/2024 | CSL Behring | Hemgenix (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $691.10 | General |
| Category: Hematology | ||||||
| 10/22/2024 | CSL Behring | Hemgenix (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $517.90 | General |
| Category: Hematology | ||||||
| 09/09/2024 | CSL Behring | Hemgenix (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,168.90 | General |
| Category: Hematology | ||||||
| 04/05/2024 | CSL Behring | Hemgenix (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $219.90 | General |
| Category: Hematology | ||||||
| 03/24/2024 | Novo Nordisk Health Care AG | NovoSeven (Biological) | Consulting Fee | Cash or cash equivalent | $4,760.00 | General |
| Category: Hemophilia | ||||||
| 12/26/2023 | PFIZER INC. | — | Travel and Lodging | Cash or cash equivalent | $95.52 | General |
| 11/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 10/27/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $653.52 | General |
| 10/27/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $449.87 | General |
| 10/27/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $303.82 | General |
| 10/25/2023 | CSL Behring | HEMGENIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $185.95 | General |
| Category: Hematology | ||||||
| 06/11/2023 | CSL Behring | HEMGENIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,232.72 | General |
| Category: Hematology | ||||||
| 06/11/2023 | CSL Behring | HEMGENIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $788.53 | General |
| Category: Hematology | ||||||
| 05/25/2023 | CSL Behring | HEMGENIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,241.95 | General |
| Category: Hematology | ||||||
| 05/25/2023 | CSL Behring | HEMGENIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $794.44 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 62 | 68 | $22,210 | $5,576 |
| 2022 | 4 | 71 | 76 | $24,060 | $5,430 |
| 2021 | 7 | 131 | 144 | $49,462 | $11,923 |
| 2020 | 2 | 43 | 49 | $14,927 | $3,345 |
Total Patients
307
Total Services
337
Medicare Billing
$26,274
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 30 | $11,660 | $3,224 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 38 | $10,550 | $2,353 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 38 | $10,564 | $2,657 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $4,656 | $1,123 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $6,096 | $1,039 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $2,744 | $609.88 | 22.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 29 | $10,913 | $2,894 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 40 | $11,109 | $2,755 | 24.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $8,991 | $1,828 | 20.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $6,924 | $1,598 | 23.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 16 | $4,881 | $1,295 | 26.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $4,153 | $967.69 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $2,491 | $585.97 | 23.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 22 | 25 | $8,674 | $1,943 | 22.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 24 | $6,253 | $1,402 | 22.4% |
About Dr. Nigel Key, MD
Dr. Nigel Key, MD is a Hematology & Oncology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831263532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nigel Key, MD has received a total of $204,110 in payments from pharmaceutical and medical device companies, with $37,030 received in 2024. These payments were reported across 169 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($137,802).
As a Medicare-enrolled provider, Key has provided services to 307 Medicare beneficiaries, totaling 337 services with total Medicare billing of $26,274. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Chapel Hill, NC
- Active Since 11/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1831263532
Products in Payments
- NovoSeven (Biological) $20,160
- HEMLIBRA (Biological) $11,766
- Non-Covered Product (Drug) $11,762
- HEMGENIX (Biological) $8,674
- ADCETRIS (Biological) $5,892
- Hemgenix (Biological) $2,598
- Alphanate (Biological) $1,200
- Idelvion (Biological) $418.18
- Alprolix (Drug) $20.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Chapel Hill
Dr. Thomas Stinchcombe, Md, MD
Hematology & Oncology — Payments: $332,239
Hematology & Oncology $332,239
Jared Weiss, M.d, M.D
Hematology & Oncology — Payments: $304,374
Hematology & Oncology $304,374
Dr. Alice Ma, Md, MD
Hematology & Oncology — Payments: $107,585
Hematology & Oncology $107,585
Dr. Norman Sharpless, Md, MD
Hematology & Oncology — Payments: $72,173
Hematology & Oncology $72,173
Dr. Lisa Carey, Md, MD
Hematology & Oncology — Payments: $58,769
Hematology & Oncology $58,769
Juneko Grilley-Olson, M.d, M.D
Hematology & Oncology — Payments: $36,255
Hematology & Oncology $36,255